Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Health Canada approves phase I study of Cardiol's ultra-pure CBD formulation

March 9, 2020

Histamine H3 receptor agonist shows a protective role against cardiorenal damage in mice

March 2, 2020

First patient enrolled in first-in-human study of NI-006

Feb. 28, 2020

Noncoding RNA protects blood vessel walls

Feb. 25, 2020

Phase III INCREASE study of Tyvaso in PH-ILD meets key endpoints

Feb. 24, 2020

Promising trend on survival observed in phase II trial of adrecizumab for septic shock

Feb. 24, 2020

DC-007D shows promise as novel thrombolytic in model of focal embolic stroke

Feb. 24, 2020

Neoral approved for acute stage Kawasaki disease in Japan

Feb. 24, 2020

BT-200 blocks VWF and platelet function in whole blood of patients with acute stroke

Feb. 21, 2020

European Commission approves Vyndaqel for ATTR-CM

Feb. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...